The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Authors
Keywords
Psoriasis, IL-17A, IL-17F, IL-17 receptor A, Innate immunity, Adaptive immunity
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-15
DOI
10.1007/s12016-018-8702-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokine production by human neutrophils: Revisiting the “dark side of the moon”
- (2018) Nicola Tamassia et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- STAT-3–independent production of IL-17 by mouse innate-like αβ T cells controls ocular infection
- (2018) Anthony J. St. Leger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A
- (2018) Yumeng Li et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- In response to Lebwohl et al, “Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials”
- (2018) Evan A. Rieder JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
- (2018) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It
- (2018) Nicola Tamassia et al. Frontiers in Immunology
- Sexy again: the renaissance of neutrophils in psoriasis
- (2017) Michael P. Schön et al. EXPERIMENTAL DERMATOLOGY
- The role of IL 23 in the treatment of psoriasis
- (2017) Lluís Puig Expert Review of Clinical Immunology
- β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
- (2017) Frank Kolbinger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing αβ T cell clones
- (2017) Tiago R. Matos et al. JOURNAL OF CLINICAL INVESTIGATION
- Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model
- (2017) Azumi Ueyama et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease
- (2017) Megan Hohenberger et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- 699 Dual IL-17A and IL-17F inhibition with bimekizumab provides evidence for IL-17F contribution to immune-mediated inflammatory skin response
- (2017) A. Maroof et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials
- (2017) Kristian Reich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis
- (2017) G. Girolomoni et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
- (2017) Peter Nash et al. LANCET
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- (2017) Kristian Reich et al. LANCET
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Clinician’s Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis
- (2016) April W. Armstrong et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Response to: ‘Let's not fool ourselves. In RA, the ACR/EULAR remission criteria are not perfect!’ by Baker et al
- (2016) Maarten Boers ANNALS OF THE RHEUMATIC DISEASES
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients
- (2016) G. Guggino et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents
- (2016) Andrea Chiricozzi et al. Expert Opinion On Drug Safety
- Safety of secukinumab in the treatment of psoriasis
- (2016) Andrew Blauvelt Expert Opinion On Drug Safety
- IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes
- (2016) Ryuta Muromoto et al. INTERNATIONAL IMMUNOLOGY
- Human mast cells capture, store, and release bioactive, exogenous IL-17A
- (2016) Troy Noordenbos et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
- (2016) Peter C.M. van de Kerkhof et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
- (2016) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
- (2016) Ajay Nirula et al. RHEUMATOLOGY
- Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris
- (2015) A. Chiricozzi et al. BRITISH JOURNAL OF DERMATOLOGY
- Dermal γδ T cells – What have we learned?
- (2015) Rebecca L. O’Brien et al. CELLULAR IMMUNOLOGY
- New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors
- (2015) Anthony A. Gaspari et al. Dermatologic Therapy
- Dermal IL-17-producing γδ T cells establish long-lived memory in the skin
- (2015) Tom Hartwig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis
- (2015) Kristian Reich et al. EXPERIMENTAL DERMATOLOGY
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
- (2015) Shunya Mashiko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An autoimmune “attack” on melanocytes triggers psoriasis and cellular hyperplasia
- (2015) James G. Krueger JOURNAL OF EXPERIMENTAL MEDICINE
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies
- (2015) Andrew Blauvelt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Harnessing the Therapeutic Potential of Th17 Cells
- (2015) Jonas Bystrom et al. MEDIATORS OF INFLAMMATION
- Genetic and epigenetic basis of psoriasis pathogenesis
- (2015) Aditi Chandra et al. MOLECULAR IMMUNOLOGY
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Basic biology and role of interleukin-17 in immunity and inflammation
- (2015) Camille Zenobia et al. PERIODONTOLOGY 2000
- Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis
- (2015) Darren D. O’Rielly et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
- (2015) Jennifer Belasco et al. Arthritis & Rheumatology
- Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid
- (2015) Emmerik F. A. Leijten et al. Arthritis & Rheumatology
- Current Concepts in Psoriatic Arthritis: Pathogenesis and Management
- (2014) K Vlam et al. ACTA DERMATO-VENEREOLOGICA
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease
- (2014) Susanne Karbach et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The IL-23/IL-17 axis in psoriatic arthritis
- (2014) Erika Suzuki et al. AUTOIMMUNITY REVIEWS
- Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling
- (2014) A. Johnston et al. BRITISH JOURNAL OF DERMATOLOGY
- Cellular sources of IL-17 in psoriasis: a paradigm shift?
- (2014) Romy R. M. C. Keijsers et al. EXPERIMENTAL DERMATOLOGY
- A lack of confirmation with alternative assays questions the validity of IL-17A expression in human neutrophils using immunohistochemistry
- (2014) Francesca Tamarozzi et al. IMMUNOLOGY LETTERS
- IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
- (2014) G. L. Stritesky et al. JOURNAL OF IMMUNOLOGY
- Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody
- (2014) C. B. Russell et al. JOURNAL OF IMMUNOLOGY
- IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human Atherosclerosis
- (2014) Christian Erbel et al. JOURNAL OF IMMUNOLOGY
- A New Player on the Psoriasis Block: IL-17A- and IL-22-Producing Innate Lymphoid Cells
- (2014) Nicole L. Ward et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR + ILC3 in Lesional Skin and Blood of Psoriasis Patients
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17 Induces Inflammation-Associated Gene Products in Blood Monocytes, and Treatment with Ixekizumab Reduces Their Expression in Psoriasis Patient Blood
- (2014) Claire Q.F. Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
- (2014) Andrea Chiricozzi et al. PLoS One
- Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease
- (2014) Xiao-Rong Xu WORLD JOURNAL OF GASTROENTEROLOGY
- Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
- (2014) Lisa GM van Baarsen et al. ARTHRITIS RESEARCH & THERAPY
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin
- (2013) B. Dyring-Andersen et al. BRITISH JOURNAL OF DERMATOLOGY
- The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer
- (2013) Lequn Li et al. CLINICAL IMMUNOLOGY
- IL-17 targeted therapies for psoriasis
- (2013) Andrea Chiricozzi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
- (2013) Bruce W. Kirkham et al. IMMUNOLOGY
- Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
- (2013) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- Dermal Clusters of Mature Dendritic Cells and T Cells Are Associated with the CCL20/CCR6 Chemokine System in Chronic Psoriasis
- (2013) Tae-Gyun Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- In Vivo Induction of Cutaneous Inflammation Results in the Accumulation of Extracellular Trap-Forming Neutrophils Expressing RORγt and IL-17
- (2013) Romy R.M.C Keijsers et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Activation of neutrophils by autocrine IL-17A–IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2
- (2013) Patricia R Taylor et al. NATURE IMMUNOLOGY
- Th17 and Th22 cells in psoriatic arthritis and psoriasis
- (2013) Helen Benham et al. ARTHRITIS RESEARCH & THERAPY
- Innate Lymphoid Cells: Balancing Immunity, Inflammation, and Tissue Repair in the Intestine
- (2012) Elia D. Tait Wojno et al. Cell Host & Microbe
- Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction
- (2012) Tabassome Simon et al. EUROPEAN HEART JOURNAL
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
- (2012) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CCR6 Is Required for Epidermal Trafficking of γδ-T Cells in an IL-23-Induced Model of Psoriasiform Dermatitis
- (2012) Tomotaka Mabuchi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CD8+ T Cells in the Lesional Skin of Atopic Dermatitis and Psoriasis Patients Are an Important Source of IFN-γ, IL-13, IL-17, and IL-22
- (2012) DirkJan Hijnen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
- (2012) David A. Martin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs
- (2012) Leanne M. Johnson-Huang et al. PLoS One
- Is Psoriatic Arthritis a Result of Abnormalities in Acquired or Innate Immunity?
- (2012) Rik J. Lories et al. Current Rheumatology Reports
- TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
- (2012) Ashish K. Marwaha et al. Frontiers in Immunology
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
- (2011) Troy Noordenbos et al. ARTHRITIS AND RHEUMATISM
- Recent advances in the IL-17 cytokine family
- (2011) Sarah L Gaffen CURRENT OPINION IN IMMUNOLOGY
- Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function
- (2011) Anne Dudeck et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
- (2011) Seon Hee Chang et al. IMMUNITY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Epidermal CCR6 + γδ T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform Dermatitis
- (2011) Tomotaka Mabuchi et al. JOURNAL OF IMMUNOLOGY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- Gone but Not Forgotten: Lesional Memory in Psoriatic Skin
- (2011) Rachael A. Clark JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CCR6 as a possible therapeutic target in psoriasis
- (2010) Michael N Hedrick et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Resolved Psoriasis Lesions Retain Expression of a Subset of Disease-Related Genes
- (2010) Mayte Suárez-Fariñas et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
- (2009) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
- (2009) Michael N. Hedrick et al. JOURNAL OF CLINICAL INVESTIGATION
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
- (2009) Shinji Kagami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- (2009) Consuelo Ortega et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques
- (2009) Onno J de Boer et al. JOURNAL OF PATHOLOGY
- A protective function for interleukin 17A in T cell–mediated intestinal inflammation
- (2009) William O'Connor Jr et al. NATURE IMMUNOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of inflammatory responses by IL-17F
- (2008) Xuexian O. Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now